N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143526 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143527 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143528 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143529 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143530 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143532 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143533 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143534 |
| CAS No | NA |
| Mol.F. | C23H29N5O2 |
| Mol.Wt. | 407.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143535 |
| CAS No | NA |
| Mol.F. | C15H17ClN4O2 |
| Mol.Wt. | 320.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143536 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143537 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143538 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143539 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143540 |
| CAS No | NA |
| Mol.F. | C7H9N3O4 |
| Mol.Wt. | 199.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |